文献速递慢性肾脏病血液净化与透析

价值医疗模式下的肾脏营养:低蛋白饮食与酮酸类似物补充延缓透析的作用

Kidney Nutrition for Value-Based Care Models: The Role of Low Protein Diets and Keto-Analogue Supplementation to Delay Dialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-09-11

本文综述了在美国慢性肾脏病管理向价值医疗模式转变的背景下,低蛋白饮食及补充酮酸类似物的极低蛋白饮食作为延缓透析的关键策略。临床试验和荟萃分析提示这些饮食可延长无透析时间并改善生活质量,但患者依从性和监测至关重要。将营养策略与辅助药物治疗整合到价值医疗中,可改善极低肾功能患者的结局并降低医疗成本。

要点

  • 低蛋白及补充酮酸类似物的极低蛋白饮食可减少含氮废物、管理尿毒症并延缓CKD进展。
  • 临床试验和荟萃分析提示补充饮食可延长无透析时间并改善生活质量,但依从性和监测至关重要。
  • 营养干预通常安全且以患者为中心,可整合入价值医疗以延缓透析启动。

核心结论

  • 在价值医疗模式下,将营养策略与辅助药物治疗整合,可为极低肾功能患者提供多模式、成本效益好的策略以改善结局并降低医疗成本。

研究设计与样本

  • 本文为综述,检索范围未在原文中明确报告。

主要发现

  • 临床试验和荟萃分析提示低蛋白及补充酮酸类似物的极低蛋白饮食可延长无透析时间并改善生活质量。
  • 补充饮食有助于纠正蛋白质能量消耗。
  • 接受此类饮食方案的患者及其照护者常报告更少的不适症状、更高的满意度及更低的交通负担。
  • 与疾病进展药物治疗相比,营养干预通常安全且以患者为中心;后者在极低肾功能(<25%正常)时常与高钾血症、急性肾损伤、感染和体重减轻相关。

关键数值与推荐

  • 原文未报告具体的推荐条款或关键数值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Government-led dialysis programs in most countries primarily focus on quality and safety measures for dialysis initiation and management. However, in the United States, CKD management may be shifting upstream of dialysis initiation toward value-based care models that prioritize delaying dialysis initiation and improving outcomes for patients with advanced CKD (stages 4 and 5 CKD). Nutritional interventions, particularly low and very low protein diets supplemented with keto-analogues of amino acids, are re-emerging as key strategies to reduce nitrogenous waste production, manage uremia, and slow CKD progression without causing malnutrition. Indeed, supplemented diets can help correct protein-energy wasting. Clinical trials and meta-analyses suggest that these diets can prolong dialysis-free periods and improve quality of life, although patient adherence and careful monitoring are crucial. This approach maintains nutritional status, while adjunct therapies, such as blood pressure control, volume management with diuretics, improved glycemic control, and anemia treatment with new oral medications, can manage comorbidities effectively without dialysis. Patients on such dietary regimens and their care partners often experience fewer unpleasant symptoms, greater satisfaction, and reduced transportation burdens. Unlike disease progression pharmacotherapies that are frequently associated with hyperkalemia, acute kidney injury, infections, and weight loss in very low kidney function (<25% of normal), nutritional interventions are usually safe and patient-centered. Incorporating nutritional strategies into value-based care aligns with cost-effectiveness, preservation of residual kidney function, and end-of-life planning, offering a holistic approach to CKD management. These interventions also support incremental dialysis transition, where keto-analogue supplemented very low protein diets continue on nondialysis days versus higher protein intake on dialysis days 1-2 times/week. Whereas quality and safety measures are needed to assess diet program success, integrating nutritional strategies with adjunct pharmacotherapy in value-based care models offers a multimodal, cost-effective strategy to improve outcomes and reduce health care costs for patients with very low kidney function without dialysis or with less frequent dialysis.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Saville J, Moore LW, Narasaki Y, et al. Kidney Nutrition for Value-Based Care Models: The Role of Low Protein Diets and Keto-Analogue Supplementation to Delay Dialysis. Clin J Am Soc Nephrol. 2025. PMID: 40932799. doi:10.2215/CJN.0000000896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。